KEGG   PATHWAY: caty04662
Entry
caty04662                   Pathway                                
Name
B cell receptor signaling pathway - Cercocebus atys (sooty mangabey)
Description
B cells are an important component of adaptive immunity. They produce and secrete millions of different antibody molecules, each of which recognizes a different (foreign) antigen. The B cell receptor (BCR) is an integral membrane protein complex that is composed of two immunoglobulin (Ig) heavy chains, two Ig light chains and two heterodimers of Ig-alpha and Ig-beta. After BCR ligation by antigen, three main protein tyrosine kinases (PTKs) -the SRC-family kinase LYN, SYK and the TEC-family kinase BTK- are activated. Phosphatidylinositol 3-kinase (PI3K) and phospholipase C-gamma 2 (PLC-gamma 2) are important downstream effectors of BCR signalling. This signalling ultimately results in the expression of immediate early genes that further activate the expression of other genes involved in B cell proliferation, differentiation and Ig production as well as other processes.
Class
Organismal Systems; Immune system
Pathway map
caty04662  B cell receptor signaling pathway
caty04662

Other DBs
GO: 0050853
Organism
Cercocebus atys (sooty mangabey) [GN:caty]
Gene
105571321  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
105571357  DAPP1; dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide [KO:K12229]
105571365  PPP3CA; serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
105571366  BANK1; B-cell scaffold protein with ankyrin repeats isoform X1 [KO:K26239]
105571369  NFKB1; nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580]
105571738  CARD11; caspase recruitment domain-containing protein 11 isoform X1 [KO:K07367]
105573773  IKBKG; NF-kappa-B essential modulator isoform X1 [KO:K07210]
105574042  [KO:K06856]
105574050  [KO:K06856]
105574052  [KO:K06856]
105574060  [KO:K06856]
105574071  [KO:K06856]
105574077  [KO:K06856]
105574081  [KO:K06856]
105574082  [KO:K06856]
105574084  [KO:K06856]
105574942  AKT3; RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
105575821  RAC2; ras-related C3 botulinum toxin substrate 2 [KO:K07860]
105575920  [KO:K06856]
105575923  [KO:K06856]
105575925  [KO:K06856]
105576501  PPP3R1; calcineurin subunit B type 1 isoform X1 [KO:K06268]
105576625  [KO:K06856]
105576626  [KO:K06856]
105576948  CR2; complement receptor type 2 isoform X1 [KO:K04012]
105577130  [KO:K06856]
105577139  [KO:K06856]
105577141  [KO:K06856]
105577142  [KO:K06856]
105577143  [KO:K06856]
105577144  [KO:K06856]
105577151  [KO:K06856]
105577187  IFITM1; interferon-induced transmembrane protein 1 [KO:K19831]
105577198  HRAS; GTPase HRas isoform X1 [KO:K02833]
105577270  CD81; CD81 antigen isoform X1 [KO:K06508]
105577432  RELA; transcription factor p65 isoform X1 [KO:K04735]
105577731  GRB2; growth factor receptor-bound protein 2 [KO:K04364]
105578169  CD22; B-cell receptor CD22 isoform X1 [KO:K06467]
105578391  RASGRP3; ras guanyl-releasing protein 3 isoform X1 [KO:K12362]
105578792  INPPL1; phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 isoform X1 [KO:K15909] [EC:3.1.3.86]
105579229  PPP3CC; serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
105579384  BLK; tyrosine-protein kinase Blk isoform X1 [KO:K08890] [EC:2.7.10.2]
105579756  SYK; tyrosine-protein kinase SYK [KO:K05855] [EC:2.7.10.2]
105580524  VAV2; guanine nucleotide exchange factor VAV2 isoform X1 [KO:K05730]
105580892  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
105581771  BLNK; B-cell linker protein isoform X1 [KO:K07371]
105581776  PIK3AP1; phosphoinositide 3-kinase adapter protein 1 isoform X1 [KO:K12230]
105581830  CHUK; inhibitor of nuclear factor kappa-B kinase subunit alpha isoform X1 [KO:K04467] [EC:2.7.11.10]
105582713  [KO:K06512]
105582715  [KO:K06512]
105582717  [KO:K06512]
105582727  [KO:K06512]
105582728  [KO:K06512]
105582730  [KO:K06512]
105582731  [KO:K06512]
105582906  [KO:K06512]
105583047  PTPN6; tyrosine-protein phosphatase non-receptor type 6 isoform X1 [KO:K05697] [EC:3.1.3.48]
105583982  NFATC3; LOW QUALITY PROTEIN: nuclear factor of activated T-cells, cytoplasmic 3 [KO:K17333]
105584356  RAC1; ras-related C3 botulinum toxin substrate 1 isoform X1 [KO:K04392]
105585038  KRAS; GTPase KRas isoform X1 [KO:K07827]
105585377  NFATC2; nuclear factor of activated T-cells, cytoplasmic 2 isoform X1 [KO:K17332]
105585803  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
105586076  PRKCB; protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
105586383  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
105586465  [KO:K06512]
105586728  SOS2; son of sevenless homolog 2 [KO:K03099]
105588248  VAV3; guanine nucleotide exchange factor VAV3 isoform X1 [KO:K05730]
105588572  RAC3; ras-related C3 botulinum toxin substrate 3 isoform X1 [KO:K07861]
105589068  NFKBIA; NF-kappa-B inhibitor alpha [KO:K04734]
105589236  FCGR2B; low affinity immunoglobulin gamma Fc region receptor II-b isoform X1 [KO:K12560]
105589398  PLCG2; LOW QUALITY PROTEIN: 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 [KO:K05859] [EC:3.1.4.11]
105589738  GSK3B; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
105589974  MALT1; mucosa-associated lymphoid tissue lymphoma translocation protein 1 isoform X1 [KO:K07369] [EC:3.4.22.-]
105590747  CD79B; B-cell antigen receptor complex-associated protein beta chain isoform X1 [KO:K06507]
105590868  FOS; proto-oncogene c-Fos [KO:K04379]
105591016  NFKBIE; LOW QUALITY PROTEIN: NF-kappa-B inhibitor epsilon [KO:K05872]
105591663  INPP5D; phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 [KO:K03084] [EC:3.1.3.86]
105591800  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 isoform X1 [KO:K04369] [EC:2.7.12.2]
105591875  VAV1; proto-oncogene vav [KO:K05730]
105592035  BTK; tyrosine-protein kinase BTK [KO:K07370] [EC:2.7.10.2]
105592167  LYN; tyrosine-protein kinase Lyn [KO:K05854] [EC:2.7.10.2]
105593014  PPP3R2; calcineurin subunit B type 2 [KO:K06268]
105593581  BCL10; B-cell lymphoma/leukemia 10 [KO:K07368]
105594283  [KO:K06856]
105594400  NFKBIB; NF-kappa-B inhibitor beta isoform X1 [KO:K02581]
105594576  PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649]
105595667  [KO:K06512]
105595672  [KO:K06512]
105595685  [KO:K06512]
105595687  [KO:K06512]
105595688  LILRA5; leukocyte immunoglobulin-like receptor subfamily A member 5 [KO:K06512]
105595759  IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1 [KO:K07209] [EC:2.7.11.10]
105595973  JUN; transcription factor AP-1 [KO:K04448]
105596344  NRAS; GTPase NRas isoform X1 [KO:K07828]
105596502  NFATC1; nuclear factor of activated T-cells, cytoplasmic 1 isoform X1 [KO:K04446]
105596769  AKT1; RAC-alpha serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
105597205  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
105597329  PPP3CB; serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
105597716  PIK3CA; LOW QUALITY PROTEIN: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
105597977  AKT2; RAC-beta serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
105598036  CD79A; B-cell antigen receptor complex-associated protein alpha chain [KO:K06506]
105598116  CD72; B-cell differentiation antigen CD72 isoform X1 [KO:K06504]
105598233  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
105598562  CD19; LOW QUALITY PROTEIN: B-lymphocyte antigen CD19 [KO:K06465]
105598850  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
105599262  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
105601165  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
Compound
C00076  Calcium cation
C00165  Diacylglycerol
C01245  D-myo-Inositol 1,4,5-trisphosphate
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Niiro H, Clark EA.
  Title
Regulation of B-cell fate by antigen-receptor signals.
  Journal
Nat Rev Immunol 2:945-56 (2002)
DOI:10.1038/nri955
Reference
  Authors
Kurosaki T.
  Title
Genetic analysis of B cell antigen receptor signaling.
  Journal
Annu Rev Immunol 17:555-92 (1999)
DOI:10.1146/annurev.immunol.17.1.555
Reference
  Authors
Nitschke L.
  Title
The role of CD22 and other inhibitory co-receptors in B-cell activation.
  Journal
Curr Opin Immunol 17:290-7 (2005)
DOI:10.1016/j.coi.2005.03.005
Reference
  Authors
Morgan BP, Marchbank KJ, Longhi MP, Harris CL, Gallimore AM.
  Title
Complement: central to innate immunity and bridging to adaptive responses.
  Journal
Immunol Lett 97:171-9 (2005)
DOI:10.1016/j.imlet.2004.11.010
Reference
  Authors
Kurosaki T.
  Title
Regulation of B-cell signal transduction by adaptor proteins.
  Journal
Nat Rev Immunol 2:354-63 (2002)
DOI:10.1038/nri801
Reference
  Authors
Nitschke L, Tsubata T.
  Title
Molecular interactions regulate BCR signal inhibition by CD22 and CD72.
  Journal
Trends Immunol 25:543-50 (2004)
DOI:10.1016/j.it.2004.08.002
Reference
  Authors
Jumaa H, Hendriks RW, Reth M.
  Title
B cell signaling and tumorigenesis.
  Journal
Annu Rev Immunol 23:415-45 (2005)
DOI:10.1146/annurev.immunol.23.021704.115606
Reference
  Authors
Rickert RC.
  Title
Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex.
  Journal
Curr Opin Immunol 17:237-43 (2005)
DOI:10.1016/j.coi.2005.03.001
Reference
  Authors
Zouali M, Sarmay G
  Title
B lymphocyte signaling pathways in systemic autoimmunity: implications for pathogenesis and treatment.
  Journal
Arthritis Rheum 50:2730-41 (2004)
DOI:10.1002/art.20487
Reference
  Authors
Chiles TC.
  Title
Regulation and function of cyclin D2 in B lymphocyte subsets.
  Journal
J Immunol 173:2901-7 (2004)
DOI:10.4049/jimmunol.173.5.2901
Reference
  Authors
Allam A, Marshall AJ
  Title
Role of the adaptor proteins Bam32, TAPP1 and TAPP2 in lymphocyte activation.
  Journal
Immunol Lett 97:7-17 (2005)
DOI:10.1016/j.imlet.2004.09.019
Reference
  Authors
Gold MR
  Title
To make antibodies or not: signaling by the B-cell antigen receptor.
  Journal
Trends Pharmacol Sci 23:316-24 (2002)
DOI:10.1016/S0165-6147(02)02045-X
Reference
PMID:9697839
  Authors
Fu C, Turck CW, Kurosaki T, Chan AC
  Title
BLNK: a central linker protein in B cell activation.
  Journal
Immunity 9:93-103 (1998)
DOI:10.1016/S1074-7613(00)80591-9
Reference
  Authors
Okada T, Maeda A, Iwamatsu A, Gotoh K, Kurosaki T
  Title
BCAP: the tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation.
  Journal
Immunity 13:817-27 (2000)
DOI:10.1016/S1074-7613(00)00079-0
Reference
  Authors
Shinohara H, Maeda S, Watarai H, Kurosaki T
  Title
IkappaB kinase beta-induced phosphorylation of CARMA1 contributes to CARMA1 Bcl10 MALT1 complex formation in B cells.
  Journal
J Exp Med 204:3285-93 (2007)
DOI:10.1084/jem.20070379
Related
pathway
caty04010  MAPK signaling pathway
caty04020  Calcium signaling pathway
caty04064  NF-kappa B signaling pathway
caty04120  Ubiquitin mediated proteolysis
caty04151  PI3K-Akt signaling pathway
caty04610  Complement and coagulation cascades
caty04810  Regulation of actin cytoskeleton
KO pathway
ko04662   

DBGET integrated database retrieval system